Streetbeat News

Regulatory

SPY

Federal Reserve's John Williams indicates uncertainty about the size of the first rate cut, noting that labor market imbalances have eased and the job market resembles pre-pandemic conditions. While it's clear that rates should fall, the pace and final rate levels remain uncertain.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 2:39 pm

TNON

Tenon Medical has received a Notice of Allowance for a U.S. patent on its systems and methods for stabilizing sacroiliac joints. This development could enhance its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 2:33 pm

MS

Massachusetts Securities Regulator fined Morgan Stanley $2 million for failing to ensure a customer was not trading on material, non-public information related to First Republic insider's stock sales.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 2:25 pm

BVNKF

BVNRY

The Democratic Republic of Congo received its first batch of mpox vaccines, nearly two years after declaring an epidemic. The vaccines, MVA-BN, are produced by Bavarian Nordic A/S and are the only approved mpox vaccines in several regions. The delay in vaccine distribution is attributed to regulatory and logistical challenges.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 2:03 pm

SPY

President Biden highlighted the importance of maintaining the historic gains for American workers in response to the August jobs data. This focus on employment could influence economic policies and market sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:50 pm

SPY

Federal Reserve's John Williams stated that future rate cuts will be data-driven, and the effects of quantitative tightening are already reflected in the markets. He emphasized that quantitative tightening is not hindering monetary policy goals, and the primary tool remains the Fed Fund Rate.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:48 pm

TAK

TEVA

VTRS

The DEA has authorized a 24% increase in production limits for Takeda's Vyvanse to address the ADHD medication shortage in the U.S. and meet international demand. This move follows the FDA's request and aims to stabilize supply amid rising demand and manufacturing delays.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 1:46 pm

CRRSF

TXT

Cirrus Aircraft, a U.S.-based private jet maker, reported strong half-year earnings with a 12% revenue increase and a 24% profit jump. However, its stock price remains under pressure due to concerns over its Chinese ownership and potential U.S. sanctions. Despite robust demand and expansion plans, Cirrus trades at a discount compared to peers like Textron.

Portfolio Pulse from The Bamboo Works

September 06, 2024 | 1:40 pm

BOX

FOXA

SNAP

YELP

Vice President Kamala Harris has received endorsements from 88 corporate leaders, including CEOs of Box Inc., Yelp Inc., and Snap Inc., for her presidential bid. This support comes amid her proposed tax reforms, including an unrealized gains tax and raising the corporate tax rate to 28%.

Portfolio Pulse from Benzinga Neuro

September 06, 2024 | 1:37 pm

PFE

VOR

Vor Biopharma Inc. (NASDAQ:VOR) announced promising clinical data from its Phase 1/2 VBP101 study for treating acute myeloid leukemia (AML) with trem-cel and Pfizer's Mylotarg. The data showed reliable engraftment and early patient benefits, leading to a 28.5% increase in VOR's stock price. Vor Bio plans to discuss a pivotal trial with the FDA and has announced a new preclinical asset, VADC45.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 1:35 pm